A method of managing non-infective nasal symptoms may include formulating a topical composition for nasal administration. The formulation may include combining about 0.25 mg to about 2 mg budesonide, about 50 mg to about 650 mg quinine sulfate, and a diluent. The topical composition may be administered nasally via irrigation or nebulization.